CJC-1295 (No DAC) 10MG

CJC-1295 (No DAC), also known as Modified GRF (1-29), is a synthetic peptide analog of growth hormone-releasing hormone (GHRH) developed for preclinical investigation into growth hormone signaling and endocrine regulation. This product is intended exclusively for academic and institutional research applications under strict regulatory oversight. Below is detailed information regarding its composition, relevance, and current research context.

Research Context

CJC-1295 (No DAC) was designed to mimic the activity of endogenous GHRH while incorporating amino acid modifications that enhance stability during laboratory research. Unlike the DAC-modified version, CJC-1295 (No DAC) has a shorter duration of activity, making it valuable for studies evaluating pulsatile growth hormone release and receptor signaling dynamics.

Researchers continue to investigate its interaction with pituitary GHRH receptors, endogenous growth hormone secretion, insulin-like growth factor-1 (IGF-1) regulation, and broader endocrine physiology. It is frequently studied independently or alongside other research peptides in controlled laboratory settings.

Research Overview

CJC-1295 (No DAC) has been evaluated in cellular and animal-based studies to assess its influence on growth hormone signaling, IGF-1 production, endocrine regulation, and metabolic physiology. Research continues to explore its pharmacokinetic properties, receptor interactions, and effects on hormone secretion patterns. Additional investigations have examined its role in tissue regeneration, body composition, exercise physiology, and healthy aging models, though these applications remain investigational.

Key Research Focus Areas

Growth Hormone Signaling

Investigation of CJC-1295 (No DAC)’s interaction with growth hormone-releasing hormone receptors and its influence on endogenous growth hormone secretion in preclinical models.

IGF-1 Regulation

Evaluation of downstream insulin-like growth factor-1 (IGF-1) signaling pathways and endocrine feedback mechanisms in laboratory research.

Endocrine Physiology

Assessment of pituitary function, hormone pulsatility, and neuroendocrine regulation in controlled experimental settings.

Metabolic Research

Exploration of potential effects on energy metabolism, nutrient utilization, and body composition within preclinical research models.

Tissue and Recovery Research

Investigation of growth factor-mediated cellular processes involved in tissue maintenance, protein synthesis, and regenerative biology under experimental conditions.

Important Compliance and Safety Information

This peptide is intended solely for research purposes and must be handled with the utmost care. Users are responsible for ensuring compliance with all applicable local, regional, and national laws and regulations governing peptide synthesis, storage, and distribution. Research institutions conducting studies involving CJC-1295 (No DAC) must adhere to Institutional Review Board (IRB) or equivalent guidelines, including laboratory safety, biosafety procedures, and animal welfare protocols where applicable.

Due to its biological activity, CJC-1295 (No DAC) requires appropriate containment and handling procedures to prevent unintended exposure. It is not intended for human or animal consumption and should not be administered outside of a controlled research environment. Always consult with a qualified researcher or academic institution before use.

For research use only. Not for human or animal consumption.